NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
- GlobeNewswire
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
New NIH Award will Initially Provide NeuroOne Approximately $200,000 through April 2027 EDEN PRAIRIE, Minn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ...
- GlobeNewswire
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
EDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on transforming the ...
- Analyst Upgrades
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5
Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech with a Buy and lowers the price target from $13 to $5. ...
- Analyst Upgrades
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5
Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech with a Buy rating and announces Price Target of $1.5. ...
- SEC
8-K Form - Current report, items 2.02, 8.01, and 9.01 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Current report, items 2.02, 8.01, and 9.01 ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- Analyst Upgrades
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3
Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech with a Buy rating and announces Price Target of $3. ...
- GlobeNewswire
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ...
- GlobeNewswire
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies ...
- Earnings Call Transcripts
NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript ...
- GlobeNewswire
NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%
Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" ...
- GlobeNewswire
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ...
- GlobeNewswire
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ...
- GlobeNewswire
NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office
Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
3 Form - Initial statement of beneficial ownership of securities - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
Initial statement of beneficial ownership of securities ...
- GlobeNewswire
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ...
- GlobeNewswire
NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025
EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ...